Factor V Leiden mutation and patent foramen ovale in ischemic stroke

Neurological Sciences

Volumn 23, Issue 5, 2002, Pages 229-231

  Bezzi, G ^a   Bolzani, W ^a   Compagnoni, V ^a   Galimi, R ^a   Palmieri, M G ^a   Bianchi, C ^b  

^a Ospedale E Morelli   (Italy)

^b Azienda Ospedaliera E Morelli   (Italy)

Author keywords

Activated protein C resistance; Cerebral ischemia; Factor V Leiden; Patent foramen ovale; Thrombophilia

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ANTICOAGULANT THERAPY; ARTERIOGRAPHY; ARTERY OCCLUSION; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CASE REPORT; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; GENE MUTATION; HEART ATRIUM SEPTUM DEFECT; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HUMAN; LABORATORY TEST; MALE; PARADOXICAL EMBOLISM; PREVALENCE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT INDICATION;

ACTIVATED PROTEIN C RESISTANCE; ANTICOAGULANTS; BRAIN ISCHEMIA; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; FACTOR V; FRONTAL LOBE; HEART SEPTAL DEFECTS, ATRIAL; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; PREVALENCE; RISK FACTORS; THROMBOPHILIA; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 0036919350     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720200046     Document Type: Article

References (17)

1. Devuyst G, Bogousslavsky J, Ruchat P, Janrenaud X, Despland PA, Regli F, Aebischer N, Karpuz HM, Castillo V, Guffi M, Sadeghi H (1996) Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transoesophageal and transcranial doppler ultrasound. Neurology 47:1162-1166
2. Stollberger C, Slany J, Schuster I, Leitner H, Winkler WB, Karnik R (1993) The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 119:461-465
3. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisemberg PR, Miletich JP (1995) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332:912-917
4. Stone DA, Godard J, Corretti MC, Kittner SJ, Sample C, Price TR, Plotnik GD (1996) Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 131:158-161
5. Royden J, Caplan LR, Come PC, Swinton NW, Breslin DJ (1983) Cerebral emboli of paradoxical origin. Ann Neurol 13:314-319
6. Hagen PT, Scolz DG, Edwards WD (1984) Incidence and size of patent foramen ovate during the first decade of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59:17-20
7. Overell JR, Bone I, Lees KR (2000) Interatrial septal abnormalities and stroke. A meta-analysis of case-control studies. Neurology 55:1172-1179
8. Schuchlenz HW, Weihs W, Horner S, Quehenberger F (2000) The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. JAMA 109:456-462
9. Mohr JP (1988) Cryptogenic stroke. N Engl J Med 318:1197-1198
10. Rosenow EC, Osmundson PJ, Brown ML (1981) Pulmonary embolism. Mayo Clin Proc 56:161-168
11. Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL (1993) Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 24:31-34
12. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dieven RJ, De Ronde H, Van Der Valden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
13. Dahlback B, Scolz DG, Suensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterised by poor anticoagulant response to activated protein C Proc Natl Acad Sci U S A 90:1004-1008
14. Griffin JH, EvattB, Wildeman C, Frenandez J (1993) Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82:1989-1993
15. Dahlback B (1997) Resistance to activated protein C caused by the R 506 Q mutation in the gene for factor V is a common risk factor for venous thrombosis. J Intern Med S740:1-8
16. Mari D, Mannucci PM, Duca F, Bertolini S, Francesci C (1996) Mutant factor V (arg 506 Glu) in healthy centenarians. Lancet 347:1044
17. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G (1996) Stroke recurrence in patients with patent foramen ovale. The Lausanne study. Neurology 46:1301-1305